It is currently Mon May 25, 2015 8:49 am

News News of Tcelna (Tovaxin)

Site map of Tcelna (Tovaxin) » Forum : Tcelna (Tovaxin)

A board to discuss Tcelna as a treatment for Multiple Sclerosis

Buy OPXA Now

Walk, no run to your brokers on Monday and buy a little bit of Opexa. Trading in high $0.40

Here is why: Partnership is going to be announced. Here is why I know

-Changed Tovaxins name to Tcelna. Why do this when tovaxin has brand awareness and was identifiable to opexa.? Partner wants to start fresh. Tcelna Websites registered to opexa 16 days ago.
-hired 12 people in last 6-7 months and hiring 4 more ...
Read more : Buy OPXA Now | Views : 1429 | Replies : 0

Tovaxin is dead....

Read more : Tovaxin is dead.... | Views : 1440 | Replies : 0

New Trail is called Abili-T

Phase IIb to start late June/early July and will be called Abili-t. Visit
Read more : New Trail is called Abili-T | Views : 1459 | Replies : 1

Tovaxin upcoming IIb? ... 143701060/
They're also calling the next trial a IIb??
Article wrote:Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has executed an agreement with Pharmaceutical Research Associates, Inc. (PRA) to provide contract research organization (CRO) services to support Opexa’s upcoming Phase IIb clinical trial for Tovaxin in patients with Secondary Progressive multiple sclerosis (SPMS). ...
Read more : Tovaxin upcoming IIb? | Views : 1675 | Replies : 1

TOVAXIN trials in Vancouver, Canada???

I have SPMS and cannot walk and would like to be on a trial for Tovaxin. Would anyone be able to help?

BTW (I do not look forward to the drawing of blood :oops: )

Thank you for your answer in advance!

Read more : TOVAXIN trials in Vancouver, Canada??? | Views : 1816 | Replies : 0

Tovaxin article in MS Journal

Read more : Tovaxin article in MS Journal | Views : 1931 | Replies : 1

Opexa Announces Publication

Read more : Opexa Announces Publication | Views : 1628 | Replies : 2

Opexa, Inc Annual Shareholder Mtg

Copy of the report, p. 31

"We currently intend to use the proceeds from the Feb 2011 public offering for general corporate purposes...and to prepare for and proceed toward the initiation of a pivotal Phase III clinical study... although the(se) proceeds would not be adequate ($7.6 million) to proceed materially beyond initiation... (dosing of the first patient) or to complete such a study...

"A pivotal Phase III ... is expected to involve 240 patients and ...
Read more : Opexa, Inc Annual Shareholder Mtg | Views : 1982 | Replies : 10


Read more : . | Views : 1932 | Replies : 1


Login  •  Register


Total posts 225588 • Total topics 23658 • Total members 15013

Contact us | Terms of Service